(Q43561584)

24 November 2017

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia (English)

1 reference

24 November 2017

0 references

0 references

0 references

1 reference

7

1 reference

24 November 2017

Norio Ozaki

9

0 references

Reiji Yoshimura

series ordinal

5

object named as

Reiji Yoshimura

1 reference

24 November 2017

8

Jun Nakamura

1 reference

24 November 2017

10

Nakao Iwata

1 reference

24 November 2017

4

Tsuyoshi Kitajima

1 reference

24 November 2017

1

Masashi Ikeda

1 reference

24 November 2017

6

Shuji Hashimoto

1 reference

24 November 2017

Yoshio Yamanouchi

2

1 reference

PubMed ID

18855532

24 November 2017

Yoko Kinoshita

series ordinal

3

1 reference

24 November 2017

1 October 2008

1 reference

24 November 2017

1 reference

24 November 2017

9

1 reference

24 November 2017

1437-1443

1 reference

24 November 2017

10

1 reference

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

24 November 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Dopamine D3 receptor Ser9Gly polymorphism and risperidone response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

The dopamine D2 receptor: new surprises from an old friend

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Association analysis of AKT1 and schizophrenia in a UK case control sample

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Further evidence of association of OPRD1 & HTR1D polymorphisms with susceptibility to anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1437

10.2217/14622416.9.10.1437

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

18855532